Green Memory Study
Alzheimer's Disease
Not Disclosed (Sponsor-led)Active
Key Facts
Indication
Alzheimer's Disease
Phase
Not Disclosed (Sponsor-led)
Status
Active
About ActivMed Practices and Research
ActivMed is a well-established, private clinical research site organization with a 30-year operational history in the New England region. It provides clinical trial services to a diverse sponsor base, from large pharmaceutical companies to local biotechs, specializing in neurology, psychiatry, dermatology, and primary care conditions. The company has adapted to decentralized trial trends by offering virtual trial capabilities and community-focused telehealth services, such as free memory screenings, to support patient recruitment and engagement. Its business model is entirely service-based, generating revenue from clinical trial contracts.
View full company profileTherapeutic Areas
Other Alzheimer's Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| NUZ-001 | Neurizon Therapeutics | Preclinical |
| ALZN002 | Alzamend Neuro | Preclinical |
| P021 | Phanes Biotech | Preclinical |
| PB43D | Phanes Biotech | Preclinical |
| UB-311 | Vaxxinity | Phase 2 |
| Lecanemab | BioArctic | Launched |
| BAN2401 | BioArctic | Preclinical |
| Undisclosed Programs | johnson-and-johnson-innovative-medicine | Pipeline |
| MK-6240 (florquinitau) | Lantheus Medical Imaging | Regulatory Filing |
| NAV-4694 (flutafuranol) | Lantheus Medical Imaging | Phase 3 |
| LNTH-2620/PI-2620 | Lantheus Medical Imaging | Phase 3 |
| itMSCs | Stemedica Cell Technologies | Clinical Development |